<?xml version="1.0" encoding="UTF-8"?>
<p>The dangerous spreading of SARS-CoV-2 has given rise to multiple attempts of repurposing of drugs initially developed against other viruses, such as hepatitis C, HIV-1, influenza, etc., along with host-targeted drugs such as hydroxychloroquine and azithromycin [
 <xref rid="B4-molecules-25-02944" ref-type="bibr">4</xref>,
 <xref rid="B5-molecules-25-02944" ref-type="bibr">5</xref>,
 <xref rid="B6-molecules-25-02944" ref-type="bibr">6</xref>,
 <xref rid="B7-molecules-25-02944" ref-type="bibr">7</xref>,
 <xref rid="B8-molecules-25-02944" ref-type="bibr">8</xref>,
 <xref rid="B9-molecules-25-02944" ref-type="bibr">9</xref>].
</p>
